According to the research report, the global consumer genomics market size is expected to touch USD 17.51 Billion by 2032, from USD 2.87 Billion in 2022, growing with a significant CAGR of 19.82% from 2023 to 2032.
The consumer genomics report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global consumer genomics in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global consumer genomics market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global consumer genomics during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3018
This study covers a detailed segmentation of the global consumer genomics market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global consumer genomics market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Ancestry
- Gene By Gene, Ltd. (FamilyTree DNA)
- 23andMe, Inc.
- Color Genomics, Inc.
- Myriad Genetics, Inc.
- Mapmygenome
- Positive Biosciences, Ltd.
- Futura Genetics
- Helix OpCo LLC
- MyHeritage Ltd.
- Pathway Genomics
- Amgen, Inc.
- Xcode Life
- Diagnomics, Inc.
- Toolbox Genomics
- SomaLogic, Inc.
- Inui Health (formerly Scanadu)
- AgeCurve
- QuickCheck Health
- Biomeb
Market Segmentation
By Applications
- Genetic Relatedness
- Diagnostics
- Lifestyle, Wellness, & Nutrition
- Ancestry
- Reproductive Health
- Personalized Medicine & Pharmacogenetic testing
- Sports Nutrition & Health
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global consumer genomics report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global consumer genomics market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Consumer Genomics Market
5.1. COVID-19 Landscape: Consumer Genomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Consumer Genomics Market, By Applications
8.1. Consumer Genomics Market, by Applications Type, 2023-2032
8.1.1. Genetic Relatedness
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Diagnostics
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Lifestyle, Wellness, & Nutrition
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Ancestry
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Reproductive Health
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Personalized Medicine & Pharmacogenetic testing
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Sports Nutrition & Health
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Consumer Genomics Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Applications (2020-2032)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Applications (2020-2032)
Chapter 10. Company Profiles
10.1. Ancestry
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Gene By Gene, Ltd. (FamilyTree DNA)
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. 23andMe, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Color Genomics, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Myriad Genetics, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Mapmygenome
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Positive Biosciences, Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Futura Genetics
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Helix OpCo LLC
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. MyHeritage Ltd.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments